Opinions
Samuel D. Isaly
OSI Pharmaceuticals Inc.
OSIP-Q
TOP PICK
Aug 13, 2004
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
$53.710
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.